Patent: 10,272,141
✉ Email this page to a colleague
Summary for Patent: 10,272,141
| Title: | Pharmaceutical preparation for the treatment of the symptoms of addiction and method of diagnosing same |
| Abstract: | A therapeutic agent for the treatment of the symptoms of addiction and the method for preparing the therapeutic agent is disclosed. The therapeutic agent is a stable pharmaceutical preparation containing, but not limited to, digestive/pancreatic enzymes. The therapeutic agent may be manufactured by a variety of encapsulation technologies. Delivery of the therapeutic agent may be made orally, through injection, by adherence of a medicated patch or other method. Further, a method of using of a biomarker, the presence of chymotrypsin in the gastrointestinal tract to determine the presence of symptoms of addiction, and the likelihood of relapsing into addiction is disclosed. |
| Inventor(s): | Joan M. Fallon |
| Assignee: | Curemark LLC |
| Application Number: | US15/593,121 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,272,141
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Auxilium Pharmaceuticals, Inc. | XIAFLEX | collagenase clostridium histolyticum | For Injection | 125338 | 2-Feb-10 | ⤷ Start Trial | 2037-05-11 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 10,272,141
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| United States of America | 11235038 | ⤷ Start Trial |
| United States of America | 2009263372 | ⤷ Start Trial |
| United States of America | 2012070504 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
